Schonfeld Strategic Advisors LLC Neuro Metrix, Inc. Transaction History

Schonfeld Strategic Advisors LLC

  • $13.8 Billion
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$5.02 - $9.82 $153,110 - $299,510
-30,500 Closed
0 $0
Q3 2021

Nov 16, 2021
BUY
$3.23 - $24.73 $98,515 - $754,265
30,500 New
30,500 $309,000

Others Institutions Holding NURO

# of Institutions
1
Shares Held
320
Call Options Held
0
Put Options Held
0
View Full List

About NeuroMetrix, Inc.

NURO Quotes by TradingView
  • Ticker NURO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 7,757,230
  • Market Cap $30.1M
  • Description
  • NeuroMetrix, Inc., a healthcare company, engages in designing, building, and marketing medical devices that stimulate and analyze nerve response for diagnostic and therapeutic purposes in the United States, Europe, Japan, China, the Middle East, and Mexico. Its primary marketed products include DPNCheck, a nerve conduction test that is used to e...
More about NURO
Track This Portfolio

Track Schonfeld Strategic Advisors LLC Portfolio

Follow Schonfeld Strategic Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email